Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer

BACKGROUND: NK cells can destroy tumor cells without prior sensitization or immunization. Tumors often lose expression of MHC molecules and/or antigens. However, NK cells can lyse tumor cells in a non-MHC-restricted manner and independent of the expression of tumor-associated antigens. NK cells are...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Transl Med
Main Authors: Sakamoto, Naoyuki, Ishikawa, Takeshi, Kokura, Satoshi, Okayama, Tetsuya, Oka, Kaname, Ideno, Mitsuko, Sakai, Fumiyo, Kato, Akiko, Tanabe, Masashige, Enoki, Tatsuji, Mineno, Junichi, Naito, Yuji, Itoh, Yoshito, Yoshikawa, Toshikazu
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4548900/
https://ncbi.nlm.nih.gov/pubmed/26303618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0632-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares